AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms.
Meynier M, Baudu E, Rolhion N, Defaye M, Straube M, Daugey V, Modoux M, Wawrzyniak I, Delbac F, Villéger R, Méleine M, Borras Nogues E, Godfraind C, Barnich N, Ardid D, Poirier P, Sokol H, Chatel JM, Langella P, Livrelli V, Bonnet M, Carvalho FA.
Meynier M, et al. Among authors: godfraind c.
Gut Microbes. 2022 Jan-Dec;14(1):2022997. doi: 10.1080/19490976.2021.2022997.
Gut Microbes. 2022.
PMID: 35090380
Free PMC article.